Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified hematologist and medical oncologist Pavankumar Tandra, MD to the statewide practice. He is providing care to patients at the Sarasota Downtown clinic located at 1970 Golf Street, Sarasota, FL 34236.
Prevention efforts, screenings and effective new treatments, many resulting from clinical research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS), have contributed to a steady decline in cancer mortality rates in the United States.
Florida Cancer Specialists & Research Institute, LLC (FCS) announced today that Lucio Gordan, MD has assumed the role of President & Managing Physician, effective January 16, 2023.
Florida Cancer Specialists & Research Institute, LLC (FCS) has announced the promotion of Trevor Heritage, PhD to Senior Vice President & Data Officer.
Get the facts about grains and their impact on your health. Discover if eating grains can contribute to a healthy lifestyle or if they should be avoided.
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome newly appointed members, Pareshkumar (Paresh) Patel, MD and Andres Soriano, MD, to its Executive Board, effective January 1, 2023.
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist William T. McGarry, MD has joined the statewide practice. He is providing care to patients in Indian River County at the Sebastian clinic, 13060 US Highway 1, Sebastian, Florida 32958 and at the Vero Beach East clinic, 3730 7th Terrace, Suite 101, Vero Beach, Florida 32960.
Ray Bailey, BPharm, RPh, Senior Vice President of Pharmacy Services for Florida Cancer Specialists & Research Institute, LLC (FCS), will retire on December 31, 2022. Bailey joined the statewide practice in 2009 and has been instrumental in developing its comprehensive Pharmacy Services division.
FCS Top News Updates
FCS Signals Next Chapter of Growth With Planned Leadership Transition and Focus on Innovation